
Digitoxin - Wikipedia
Digitoxin is a cardiac glycoside used for the treatment of heart failure and certain kinds of heart arrhythmia. It is a phytosteroid and is similar in structure and effects to digoxin, though the effects are …
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Aug 29, 2025 · Treatment with digitoxin led to a lower combined risk of death from any cause or hospital admission for worsening heart failure than placebo among patients with heart failure and reduced …
Digitoxin: Uses, Interactions, Mechanism of Action | DrugBank Online
Digitoxin is a cardiac glycoside used in the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.
Digitoxin | C41H64O13 | CID 441207 - PubChem
Some clinicians believe that digitoxin is the cardiac glycoside of choice in patients with renal failure because elimination half life in unchanged in these patients; however, digitoxin is no longer …
Digitoxin: Uses, Dosage, Side Effects, Food Interaction & FAQ
Jan 7, 2025 · Learn about Digitoxin uses, dosage, side effects, food interactions, and more. Get all the details about Digitoxin from MedicinesFAQ.
Digitoxin - an overview | ScienceDirect Topics
Digitoxin is a lipid-soluble cardiac glycoside that is used to treat congestive heart failure, arrhythmias, and heart failure. It works by blocking the sodium-potassium ATPase in the plasma membrane, …
Digitoxin - healthencyclopedia.org
Digitoxin is a cardiac glycoside medication used to treat various heart conditions, such as congestive heart failure and certain arrhythmias. Chemically, digitoxin is a phytosteroid with the formula …
Benefit of digitoxin therapy for HFrEF - Nature
Sep 11, 2025 · The investigators believe that the results of the DIGIT-HF trial support the addition of digitoxin to the range of drugs available for the evidence-based treatment of patients with HFrEF.
CAUTION: Digitoxin is extremely poisonous and should be handled with care. Definition. Digitoxin contains not less than 95.0% and not more than 105.0% of C41H64O13, calculated with reference to …
DIGitoxin to Improve ouTcomes in patients with advanced chronic …
Jun 30, 2025 · DIGIT-HF is a randomized, double-blind, parallel-group, placebo-controlled, two-arm, multicentre, event-driven phase IV trial evaluating the efficacy and safety of digitoxin compared to …